Eculizumab, Poor Response To
Clinical Features
Phenotypes and symptoms related to Eculizumab, Poor Response To
- Hemoglobinuria
- Paroxysmal nocturnal hemoglobinuria
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Eculizumab, Poor Response To Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Atypical hemolytic uremic syndrome.
By Northern Molecular Genetics Service Newcastle Upon Tyne Hospitals NHS Foundation Trust (United Kingdom).
CFB, THBD, C3, C5, ADAMTS13, INF2, MMACHC, DGKE, CFH, CFI, CD46
Specificity
10 %
Genes
100 % |
C5 deficiency.
By Centogene AG - the Rare Disease Company (Germany).
C5
Specificity
100 %
Genes
100 % |
Complement deficiencies Panel.
By CeGaT GmbH (Germany).
CFB, THBD, SERPING1, C1QA, C1QB, C1QC, C1R, C1S, C2, C3, C4A, C4B, C5, C6, C7, C8A, C8B, C8G, C9, CD59 , (...)
View the complete list with 14 more genes
Specificity
3 %
Genes
100 % |
C5.
By Fulgent Genetics Fulgent Genetics (United States).
C5
Specificity
100 %
Genes
100 % |
Complement System Disorder Panel.
By Blueprint Genetics (Finland).
CFB, SPAG1, THBD, SERPING1, RSPH1, C1QA, C1QB, C1QBP, C1QC, C1S, C2, VTN, C3, C3AR1, C4BPA, C4BPB, C5, C5AR1, C6, C7 , (...)
View the complete list with 55 more genes
Specificity
2 %
Genes
100 % |
You can get up to -3 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC NEUROFIBROMATOSIS-NOONAN SYNDROME MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT FG SYNDROME 4; FGS4 LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD FARBER LIPOGRANULOMATOSIS; FRBRL AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME